Douglas Livingston
Foot & Ankle Surgery · North Bellmore, NYNPI 1558363002
Payments from drug & device makers
What this record shows
This record is dominated by other: $28,000 of the $28,536 with a category attached, or 98.1%. Convatec Inc. accounts for 98.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $28,075 and has fallen 99.5% since, to $139 in 2025. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 10 payments — averaging $2853.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$28K
- Abbott$293
- AbbVie$125
- Smith+Nephew$50
- DJO, LLC$37
- Triad Life Sciences Inc.$30
What the payments were for
- Food & beverage$5362%
- Other$28,00098%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 3 | $28,000 |
| Abbott | 2 | $293 |
| AbbVie | 1 | $125 |
| Smith+Nephew | 2 | $50 |
| DJO, LLC | 1 | $37 |
| Triad Life Sciences Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$28,000
- PROCLAIM$154
- ESPRIT$139
How this compares
$28,536 in reported general payments places this provider in the 90th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 25 | $164 |
| Clindamycin Hcl | 13 | $143 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $62 |
| Ibuprofen | 18 | $45 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in North Bellmore
- James McWilliamHarrison$4.7M
- Jonathan DelandNew York$4M
- George Vitole Roy$2.5M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$597K
- John KennedyNew York$534K
- Michael KellerKingston$532K
- Judith BaumhauerRochester$328K
- Stuart MogulNew York$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.